Act No. 1668 on a pilot scheme for medicinal cannabis. Pays/Territoire Danemark Type du document Législation Date 2017 Source FAO, FAOLEX Sujet Plantes cultivées Mot clé Cultures interdites Commerce international Emballage/étiquetage Transformation/manutention Santé publique Aire géographique Europe, Europe et Asie Centrale, Pays de l'Union Européenne, Mer du Nord, Atlantique du Nord-Est, Europe du Nord Entry into force notes This Act enters into force on 1 January 2018. Résumé The present Act establishes a pilot scheme for medicinal cannabis for the treatment of humans, from 1 January 2018 to 31 December 2021. The Act does not apply to cannabis-containing medicinal products that are regulated under the provisions of the Medicines Act. Cannabis raw materials, cannabis intermediate products, and cannabis end products, as defined by this Act, are exempt from the Medicines Act and the Pharmacy Act, unless otherwise is specified. Texte intégral Danois Site web www.retsinformation.dk Références - Législation Implementé par Order No. 2538 on intermediate cannabis products. Législation | Danemark | 2021 Mot clé: Cultures interdites, Commerce intérieur, Commerce international, Transport/dépôt, Emballage/étiquetage, Transformation/manutention, Santé publique, Autorisation/permis Source: FAO, FAOLEX Order No. 2539 on cannabis bulk and cannabis raw materials. Législation | Danemark | 2021 Mot clé: Protection du consommateur, Production végétale, Cultures interdites, Plantes oléagineuses, Commerce international, Transformation/manutention, Questions de procédures, Santé publique Source: FAO, FAOLEX Order No. 2501 on pharmacies' production of cannabis end products. Législation | Danemark | 2021 Mot clé: Protection du consommateur, Plantes oléagineuses, Cultures interdites, Emballage/étiquetage, Transformation/manutention, Santé publique, Inspection Source: FAO, FAOLEX